유유제약2우B

000227KOSPI

54.0 / 100

Reference Date: 2026-07-24

Financial Score25.5 / 40

News Sentiment12.5 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Plunged 27.4% over the past month, with no recent news.

Score Calculation Basis

Detailed Financial Score

PER

15.22Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.02Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

6.62Industry Average 8.002.5Point

Below industry avg

Debt Ratio

5.50Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲1551.5% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 3.4% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (22%)

Current 7,490Won52-week high 11,67052-week low 6,300

1-month return0.0Point

1m -27.35% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0